BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36083778)

  • 21. Copy number variation analysis of m
    Wang X; Yu J; Chen J; Hou Y; Du Z; Huang H; Tang S; Han Y; Ding C; Xue Z
    Cancer Med; 2021 Nov; 10(21):7804-7815. PubMed ID: 34668652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma.
    Liu C; Gao J; Yang D; Yu Q; Zhang S
    Front Pharmacol; 2022; 13():907433. PubMed ID: 35662721
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
    Wang L; Wang Y; Wang J; Li L; Bi J
    J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
    Liu Z; Xu H; Weng S; Ren Y; Han X
    Front Immunol; 2022; 13():828330. PubMed ID: 35154148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a ten-long noncoding RNA signature for predicting the survival and immune status of patients with bladder urothelial carcinoma based on the GEO database: a superior machine learning model.
    Mao X; Chen S; Li G
    Aging (Albany NY); 2021 Feb; 13(5):6957-6981. PubMed ID: 33621953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
    Guo Y; Yin J; Dai Y; Guan Y; Chen P; Chen Y; Huang C; Lu YJ; Zhang L; Song D
    Front Cell Dev Biol; 2021; 9():642650. PubMed ID: 34540821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.
    Riester M; Taylor JM; Feifer A; Koppie T; Rosenberg JE; Downey RJ; Bochner BH; Michor F
    Clin Cancer Res; 2012 Mar; 18(5):1323-33. PubMed ID: 22228636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.
    Zhang P; Liu Z; Wang D; Li Y; Xing Y; Xiao Y
    Front Immunol; 2021; 12():724541. PubMed ID: 34512654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.
    Zhang F; Liang J; Feng D; Liu S; Wu J; Tang Y; Liu Z; Lu Y; Wang X; Wei X
    Front Cell Dev Biol; 2022; 10():814735. PubMed ID: 35281080
    [No Abstract]   [Full Text] [Related]  

  • 35. Identifying and optimizing human endometrial gene expression signatures for endometrial dating.
    Diaz-Gimeno P; Sebastian-Leon P; Sanchez-Reyes JM; Spath K; Aleman A; Vidal C; Devesa-Peiro A; Labarta E; Sánchez-Ribas I; Ferrando M; Kohls G; García-Velasco JA; Seli E; Wells D; Pellicer A
    Hum Reprod; 2022 Jan; 37(2):284-296. PubMed ID: 34875061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes.
    Burgess EF; Sanders JA; Livasy C; Symanowski J; Gatalica Z; Steuerwald NM; Arguello D; Brouwer CR; Korn WM; Grigg CM; Zhu J; Matulay JT; Clark PE; Heath EI; Raghavan D
    Urol Oncol; 2022 Aug; 40(8):383.e1-383.e10. PubMed ID: 35662501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
    Zhang C; Shen L; Qi F; Wang J; Luo J
    J Cell Physiol; 2020 Apr; 235(4):3849-3863. PubMed ID: 31596511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
    Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
    Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
    Zhang F; Wang X; Hu H; Yang Y; Wang J; Tang Y; Li D; Bai Y; Han P
    Bioengineered; 2021 Dec; 12(1):3802-3823. PubMed ID: 34281486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.
    Iyer G; Al-Ahmadie H; Schultz N; Hanrahan AJ; Ostrovnaya I; Balar AV; Kim PH; Lin O; Weinhold N; Sander C; Zabor EC; Janakiraman M; Garcia-Grossman IR; Heguy A; Viale A; Bochner BH; Reuter VE; Bajorin DF; Milowsky MI; Taylor BS; Solit DB
    J Clin Oncol; 2013 Sep; 31(25):3133-40. PubMed ID: 23897969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.